Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease
Identifieur interne : 000204 ( Main/Corpus ); précédent : 000203; suivant : 000205Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease
Auteurs : H. Baas ; K. Stecker ; A. FischerSource :
- Journal of Neural Transmission - Parkinson's Disease and Dementia Section [ 0936-3076 ] ; 1993-02-01.
Abstract
Summary: Despite widespread use in pharmacotherapeutical trials, in the majority of rating scales used in Parkinson's disease (PD) validity, reliability and appropriate use have never been confirmed by statistical data. For this reason 350 unselected PD-pats. were investigated by an extensive standardized test-battery including registration of basis data, Columbia University Rating Scale (CURS), scale for assessment of functional disability (ADL), SCAG-scale, Hoehn & Jahr-scale (HY), mod. Webster step second-test (WSST), Purduepegboard, questionnaire for subjective complaints (SC), WDG, LPS1/2, 3/4, 6, 7, 10, clinical assessment of dementia, v. Zerssen-scale and orthostatic hypotension (60° tilt up). For CURS, SCAG and ADL instrumental reliability was calculated by Cronbach's alpha. For CURS, SCAG, ADL and the total data of complete test battery (CTB) principal component analysis (PCA) was performed for data reduction. CURS, SCAG and ADL showed high internal consistency (alpha ∼≥0.9). For CURS 5 factors accounting for 66% total variance could be extracted by PCA. They represent gait, rigidity, tremor, right/left dexterity (eigenvalues >1). For SCAG 3 factors (61% of total variance) representing dementia, depression and change of personality were extracted. For ADL 3 factors (67% of total variance) could be extracted, representing overall functional disability, handwriting and disablity by pain. PCA of the CTB identified 8 interpretable factors (66% of total variance) characterizing at least partially the clinical profile of PD: 1. motor disability (assessment by rating-scales) 2. dementia, 3. motor-disability (assessment by apparative measurements), 4. depression, 5. orthostatic hypotension, 6. WDG, 7. tremor and 8. pain. Our data confirm the suitability of the investigated scales and give a rational base for their appropriate use in a sense of data reduction and economical evaluation.
Url:
DOI: 10.1007/BF02260914
Links to Exploration step
ISTEX:338D77248FE54558E599974EF584E5A171C180CDLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</title><author><name sortKey="Baas, H" sort="Baas, H" uniqKey="Baas H" first="H." last="Baas">H. Baas</name><affiliation><mods:affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</mods:affiliation></affiliation></author><author><name sortKey="Stecker, K" sort="Stecker, K" uniqKey="Stecker K" first="K." last="Stecker">K. Stecker</name><affiliation><mods:affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</mods:affiliation></affiliation></author><author><name sortKey="Fischer, A" sort="Fischer, A" uniqKey="Fischer A" first="A." last="Fischer">A. Fischer</name><affiliation><mods:affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:338D77248FE54558E599974EF584E5A171C180CD</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1007/BF02260914</idno><idno type="url">https://api.istex.fr/document/338D77248FE54558E599974EF584E5A171C180CD/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000204</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</title><author><name sortKey="Baas, H" sort="Baas, H" uniqKey="Baas H" first="H." last="Baas">H. Baas</name><affiliation><mods:affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</mods:affiliation></affiliation></author><author><name sortKey="Stecker, K" sort="Stecker, K" uniqKey="Stecker K" first="K." last="Stecker">K. Stecker</name><affiliation><mods:affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</mods:affiliation></affiliation></author><author><name sortKey="Fischer, A" sort="Fischer, A" uniqKey="Fischer A" first="A." last="Fischer">A. Fischer</name><affiliation><mods:affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neural Transmission - Parkinson's Disease and Dementia Section</title><title level="j" type="abbrev">J Neural Transm Gen Sect</title><idno type="ISSN">0936-3076</idno><idno type="eISSN">1435-1463</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><date type="published" when="1993-02-01">1993-02-01</date><biblScope unit="volume">5</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="45">45</biblScope><biblScope unit="page" to="61">61</biblScope></imprint><idno type="ISSN">0936-3076</idno></series><idno type="istex">338D77248FE54558E599974EF584E5A171C180CD</idno><idno type="DOI">10.1007/BF02260914</idno><idno type="ArticleID">Art6</idno><idno type="ArticleID">BF02260914</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0936-3076</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary: Despite widespread use in pharmacotherapeutical trials, in the majority of rating scales used in Parkinson's disease (PD) validity, reliability and appropriate use have never been confirmed by statistical data. For this reason 350 unselected PD-pats. were investigated by an extensive standardized test-battery including registration of basis data, Columbia University Rating Scale (CURS), scale for assessment of functional disability (ADL), SCAG-scale, Hoehn & Jahr-scale (HY), mod. Webster step second-test (WSST), Purduepegboard, questionnaire for subjective complaints (SC), WDG, LPS1/2, 3/4, 6, 7, 10, clinical assessment of dementia, v. Zerssen-scale and orthostatic hypotension (60° tilt up). For CURS, SCAG and ADL instrumental reliability was calculated by Cronbach's alpha. For CURS, SCAG, ADL and the total data of complete test battery (CTB) principal component analysis (PCA) was performed for data reduction. CURS, SCAG and ADL showed high internal consistency (alpha ∼≥0.9). For CURS 5 factors accounting for 66% total variance could be extracted by PCA. They represent gait, rigidity, tremor, right/left dexterity (eigenvalues >1). For SCAG 3 factors (61% of total variance) representing dementia, depression and change of personality were extracted. For ADL 3 factors (67% of total variance) could be extracted, representing overall functional disability, handwriting and disablity by pain. PCA of the CTB identified 8 interpretable factors (66% of total variance) characterizing at least partially the clinical profile of PD: 1. motor disability (assessment by rating-scales) 2. dementia, 3. motor-disability (assessment by apparative measurements), 4. depression, 5. orthostatic hypotension, 6. WDG, 7. tremor and 8. pain. Our data confirm the suitability of the investigated scales and give a rational base for their appropriate use in a sense of data reduction and economical evaluation.</div></front></TEI><istex><corpusName>springer</corpusName><author><json:item><name>Dr. H. Baas</name><affiliations><json:string>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</json:string></affiliations></json:item><json:item><name>K. Stecker</name><affiliations><json:string>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</json:string></affiliations></json:item><json:item><name>P. A. Fischer</name><affiliations><json:string>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</json:string></affiliations></json:item></author><articleId><json:string>Art6</json:string><json:string>BF02260914</json:string></articleId><language><json:string>eng</json:string></language><abstract>Summary: Despite widespread use in pharmacotherapeutical trials, in the majority of rating scales used in Parkinson's disease (PD) validity, reliability and appropriate use have never been confirmed by statistical data. For this reason 350 unselected PD-pats. were investigated by an extensive standardized test-battery including registration of basis data, Columbia University Rating Scale (CURS), scale for assessment of functional disability (ADL), SCAG-scale, Hoehn & Jahr-scale (HY), mod. Webster step second-test (WSST), Purduepegboard, questionnaire for subjective complaints (SC), WDG, LPS1/2, 3/4, 6, 7, 10, clinical assessment of dementia, v. Zerssen-scale and orthostatic hypotension (60° tilt up). For CURS, SCAG and ADL instrumental reliability was calculated by Cronbach's alpha. For CURS, SCAG, ADL and the total data of complete test battery (CTB) principal component analysis (PCA) was performed for data reduction. CURS, SCAG and ADL showed high internal consistency (alpha ∼≥0.9). For CURS 5 factors accounting for 66% total variance could be extracted by PCA. They represent gait, rigidity, tremor, right/left dexterity (eigenvalues >1). For SCAG 3 factors (61% of total variance) representing dementia, depression and change of personality were extracted. For ADL 3 factors (67% of total variance) could be extracted, representing overall functional disability, handwriting and disablity by pain. PCA of the CTB identified 8 interpretable factors (66% of total variance) characterizing at least partially the clinical profile of PD: 1. motor disability (assessment by rating-scales) 2. dementia, 3. motor-disability (assessment by apparative measurements), 4. depression, 5. orthostatic hypotension, 6. WDG, 7. tremor and 8. pain. Our data confirm the suitability of the investigated scales and give a rational base for their appropriate use in a sense of data reduction and economical evaluation.</abstract><qualityIndicators><score>8</score><pdfVersion>1.3</pdfVersion><pdfPageSize>576 x 774 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1918</abstractCharCount><pdfWordCount>6060</pdfWordCount><pdfCharCount>36532</pdfCharCount><pdfPageCount>17</pdfPageCount><abstractWordCount>272</abstractWordCount></qualityIndicators><title>Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</title><genre><json:string>research-article</json:string></genre><host><volume>5</volume><pages><last>61</last><first>45</first></pages><issn><json:string>0936-3076</json:string></issn><issue>1</issue><subject><json:item><value>Pharmacology/Toxicology</value></json:item><json:item><value>Psychiatry</value></json:item><json:item><value>Neurology</value></json:item></subject><journalId><json:string>722</json:string></journalId><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1435-1463</json:string></eissn><title>Journal of Neural Transmission - Parkinson's Disease and Dementia Section</title><publicationDate>1993</publicationDate><copyrightDate>1993</copyrightDate></host><publicationDate>1993</publicationDate><copyrightDate>1993</copyrightDate><doi><json:string>10.1007/BF02260914</json:string></doi><id>338D77248FE54558E599974EF584E5A171C180CD</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/338D77248FE54558E599974EF584E5A171C180CD/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/338D77248FE54558E599974EF584E5A171C180CD/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/338D77248FE54558E599974EF584E5A171C180CD/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</title><respStmt xml:id="ISTEX-API" resp="Références bibliographiques récupérées via GROBID" name="ISTEX-API (INIST-CNRS)"></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><availability><p>SPRINGER</p></availability><date>1991-10-16</date></publicationStmt><notesStmt><note>Full Papers</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</title><author><persName><forename type="first">H.</forename><surname>Baas</surname></persName><roleName type="degree">Dr.</roleName><affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</affiliation></author><author><persName><forename type="first">K.</forename><surname>Stecker</surname></persName><affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</affiliation></author><author><persName><forename type="first">P.</forename><surname>Fischer</surname></persName><affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</affiliation></author></analytic><monogr><title level="j">Journal of Neural Transmission - Parkinson's Disease and Dementia Section</title><title level="j" type="abbrev">J Neural Transm Gen Sect</title><idno type="JournalID">722</idno><idno type="pISSN">0936-3076</idno><idno type="eISSN">1435-1463</idno><idno type="IssueArticleCount">9</idno><idno type="VolumeIssueCount">3</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><date type="published" when="1993-02-01"></date><biblScope unit="volume">5</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="45">45</biblScope><biblScope unit="page" to="61">61</biblScope></imprint></monogr><idno type="istex">338D77248FE54558E599974EF584E5A171C180CD</idno><idno type="DOI">10.1007/BF02260914</idno><idno type="ArticleID">Art6</idno><idno type="ArticleID">BF02260914</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1991-10-16</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Summary: Despite widespread use in pharmacotherapeutical trials, in the majority of rating scales used in Parkinson's disease (PD) validity, reliability and appropriate use have never been confirmed by statistical data. For this reason 350 unselected PD-pats. were investigated by an extensive standardized test-battery including registration of basis data, Columbia University Rating Scale (CURS), scale for assessment of functional disability (ADL), SCAG-scale, Hoehn & Jahr-scale (HY), mod. Webster step second-test (WSST), Purduepegboard, questionnaire for subjective complaints (SC), WDG, LPS1/2, 3/4, 6, 7, 10, clinical assessment of dementia, v. Zerssen-scale and orthostatic hypotension (60° tilt up). For CURS, SCAG and ADL instrumental reliability was calculated by Cronbach's alpha. For CURS, SCAG, ADL and the total data of complete test battery (CTB) principal component analysis (PCA) was performed for data reduction. CURS, SCAG and ADL showed high internal consistency (alpha ∼≥0.9). For CURS 5 factors accounting for 66% total variance could be extracted by PCA. They represent gait, rigidity, tremor, right/left dexterity (eigenvalues >1). For SCAG 3 factors (61% of total variance) representing dementia, depression and change of personality were extracted. For ADL 3 factors (67% of total variance) could be extracted, representing overall functional disability, handwriting and disablity by pain. PCA of the CTB identified 8 interpretable factors (66% of total variance) characterizing at least partially the clinical profile of PD: 1. motor disability (assessment by rating-scales) 2. dementia, 3. motor-disability (assessment by apparative measurements), 4. depression, 5. orthostatic hypotension, 6. WDG, 7. tremor and 8. pain. Our data confirm the suitability of the investigated scales and give a rational base for their appropriate use in a sense of data reduction and economical evaluation.</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>Medicine & Public Health</head><item><term>Pharmacology/Toxicology</term></item><item><term>Psychiatry</term></item><item><term>Neurology</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1991-10-16">Created</change><change when="1993-02-01">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-3-2">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/338D77248FE54558E599974EF584E5A171C180CD/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Springer, Publisher found" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//Springer-Verlag//DTD A++ V2.4//EN" URI="http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd" name="istex:docType"></istex:docType><istex:document><Publisher><PublisherInfo><PublisherName>Springer-Verlag</PublisherName><PublisherLocation>Vienna</PublisherLocation></PublisherInfo><Journal><JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered"><JournalID>722</JournalID><JournalPrintISSN>0936-3076</JournalPrintISSN><JournalElectronicISSN>1435-1463</JournalElectronicISSN><JournalTitle>Journal of Neural Transmission - Parkinson's Disease and Dementia Section</JournalTitle><JournalAbbreviatedTitle>J Neural Transm Gen Sect</JournalAbbreviatedTitle><JournalSubjectGroup><JournalSubject Type="Primary">Medicine & Public Health</JournalSubject><JournalSubject Type="Secondary">Pharmacology/Toxicology</JournalSubject><JournalSubject Type="Secondary">Psychiatry</JournalSubject><JournalSubject Type="Secondary">Neurology</JournalSubject></JournalSubjectGroup></JournalInfo><Volume><VolumeInfo VolumeType="Regular" TocLevels="0"><VolumeIDStart>5</VolumeIDStart><VolumeIDEnd>5</VolumeIDEnd><VolumeIssueCount>3</VolumeIssueCount></VolumeInfo><Issue IssueType="Regular"><IssueInfo TocLevels="0"><IssueIDStart>1</IssueIDStart><IssueIDEnd>1</IssueIDEnd><IssueArticleCount>9</IssueArticleCount><IssueHistory><CoverDate><DateString>1993</DateString><Year>1993</Year><Month>2</Month></CoverDate></IssueHistory><IssueCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>1993</CopyrightYear></IssueCopyright></IssueInfo><Article ID="Art6"><ArticleInfo Language="En" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" TocLevels="0" ContainsESM="No"><ArticleID>BF02260914</ArticleID><ArticleDOI>10.1007/BF02260914</ArticleDOI><ArticleSequenceNumber>6</ArticleSequenceNumber><ArticleTitle Language="En">Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</ArticleTitle><ArticleCategory>Full Papers</ArticleCategory><ArticleFirstPage>45</ArticleFirstPage><ArticleLastPage>61</ArticleLastPage><ArticleHistory><RegistrationDate><Year>2005</Year><Month>11</Month><Day>9</Day></RegistrationDate><Received><Year>1991</Year><Month>10</Month><Day>16</Day></Received><Accepted><Year>1992</Year><Month>4</Month><Day>8</Day></Accepted></ArticleHistory><ArticleCopyright><CopyrightHolderName>Springer-Verlag</CopyrightHolderName><CopyrightYear>1993</CopyrightYear></ArticleCopyright><ArticleGrants Type="Regular"><MetadataGrant Grant="OpenAccess"></MetadataGrant><AbstractGrant Grant="OpenAccess"></AbstractGrant><BodyPDFGrant Grant="Restricted"></BodyPDFGrant><BodyHTMLGrant Grant="Restricted"></BodyHTMLGrant><BibliographyGrant Grant="Restricted"></BibliographyGrant><ESMGrant Grant="Restricted"></ESMGrant></ArticleGrants><ArticleContext><JournalID>722</JournalID><VolumeIDStart>5</VolumeIDStart><VolumeIDEnd>5</VolumeIDEnd><IssueIDStart>1</IssueIDStart><IssueIDEnd>1</IssueIDEnd></ArticleContext></ArticleInfo><ArticleHeader><AuthorGroup><Author AffiliationIDS="Aff1" PresentAffiliationID="Aff1"><AuthorName DisplayOrder="Western"><Prefix>Dr.</Prefix><GivenName>H.</GivenName><FamilyName>Baas</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>K.</GivenName><FamilyName>Stecker</FamilyName></AuthorName></Author><Author AffiliationIDS="Aff1"><AuthorName DisplayOrder="Western"><GivenName>P.</GivenName><GivenName>A.</GivenName><FamilyName>Fischer</FamilyName></AuthorName></Author><Affiliation ID="Aff1"><OrgDivision>Department of Neurology</OrgDivision><OrgName>University of Frankfurt/Main</OrgName><OrgAddress><Street>Schleusenweg 2-16</Street><Postcode>D-W-6000</Postcode><City>Frankfurt/Main</City><Country>Federal Republic of Germany</Country></OrgAddress></Affiliation></AuthorGroup><Abstract ID="Abs1" Language="En"><Heading>Summary</Heading><Para>Despite widespread use in pharmacotherapeutical trials, in the majority of rating scales used in Parkinson's disease (PD) validity, reliability and appropriate use have never been confirmed by statistical data. For this reason 350 unselected PD-pats. were investigated by an extensive standardized test-battery including registration of basis data, Columbia University Rating Scale (CURS), scale for assessment of functional disability (ADL), SCAG-scale, Hoehn & Jahr-scale (HY), mod. Webster step second-test (WSST), Purduepegboard, questionnaire for subjective complaints (SC), WDG, LPS1/2, 3/4, 6, 7, 10, clinical assessment of dementia, v. Zerssen-scale and orthostatic hypotension (60° tilt up). For CURS, SCAG and ADL instrumental reliability was calculated by Cronbach's alpha. For CURS, SCAG, ADL and the total data of complete test battery (CTB) principal component analysis (PCA) was performed for data reduction. CURS, SCAG and ADL showed high internal consistency (alpha ∼≥0.9). For CURS 5 factors accounting for 66% total variance could be extracted by PCA. They represent gait, rigidity, tremor, right/left dexterity (eigenvalues >1). For SCAG 3 factors (61% of total variance) representing dementia, depression and change of personality were extracted. For ADL 3 factors (67% of total variance) could be extracted, representing overall functional disability, handwriting and disablity by pain. PCA of the CTB identified 8 interpretable factors (66% of total variance) characterizing at least partially the clinical profile of PD: 1. motor disability (assessment by rating-scales) 2. dementia, 3. motor-disability (assessment by apparative measurements), 4. depression, 5. orthostatic hypotension, 6. WDG, 7. tremor and 8. pain. Our data confirm the suitability of the investigated scales and give a rational base for their appropriate use in a sense of data reduction and economical evaluation.</Para></Abstract><KeywordGroup Language="En"><Heading>Keywords</Heading><Keyword>Parkinson-syndrome</Keyword><Keyword>clinical documentation</Keyword><Keyword>statistical analysis</Keyword><Keyword>rating scales</Keyword><Keyword>statistical evaluation</Keyword></KeywordGroup></ArticleHeader><NoBody></NoBody></Article></Issue></Volume></Journal></Publisher></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease</title></titleInfo><name type="personal"><namePart type="termsOfAddress">Dr.</namePart><namePart type="given">H.</namePart><namePart type="family">Baas</namePart><affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Stecker</namePart><affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="given">A.</namePart><namePart type="family">Fischer</namePart><affiliation>Department of Neurology, University of Frankfurt/Main, Schleusenweg 2-16, D-W-6000, Frankfurt/Main, Federal Republic of Germany</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="OriginalPaper"></genre><originInfo><publisher>Springer-Verlag</publisher><place><placeTerm type="text">Vienna</placeTerm></place><dateCreated encoding="w3cdtf">1991-10-16</dateCreated><dateIssued encoding="w3cdtf">1993-02-01</dateIssued><copyrightDate encoding="w3cdtf">1993</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Summary: Despite widespread use in pharmacotherapeutical trials, in the majority of rating scales used in Parkinson's disease (PD) validity, reliability and appropriate use have never been confirmed by statistical data. For this reason 350 unselected PD-pats. were investigated by an extensive standardized test-battery including registration of basis data, Columbia University Rating Scale (CURS), scale for assessment of functional disability (ADL), SCAG-scale, Hoehn & Jahr-scale (HY), mod. Webster step second-test (WSST), Purduepegboard, questionnaire for subjective complaints (SC), WDG, LPS1/2, 3/4, 6, 7, 10, clinical assessment of dementia, v. Zerssen-scale and orthostatic hypotension (60° tilt up). For CURS, SCAG and ADL instrumental reliability was calculated by Cronbach's alpha. For CURS, SCAG, ADL and the total data of complete test battery (CTB) principal component analysis (PCA) was performed for data reduction. CURS, SCAG and ADL showed high internal consistency (alpha ∼≥0.9). For CURS 5 factors accounting for 66% total variance could be extracted by PCA. They represent gait, rigidity, tremor, right/left dexterity (eigenvalues >1). For SCAG 3 factors (61% of total variance) representing dementia, depression and change of personality were extracted. For ADL 3 factors (67% of total variance) could be extracted, representing overall functional disability, handwriting and disablity by pain. PCA of the CTB identified 8 interpretable factors (66% of total variance) characterizing at least partially the clinical profile of PD: 1. motor disability (assessment by rating-scales) 2. dementia, 3. motor-disability (assessment by apparative measurements), 4. depression, 5. orthostatic hypotension, 6. WDG, 7. tremor and 8. pain. Our data confirm the suitability of the investigated scales and give a rational base for their appropriate use in a sense of data reduction and economical evaluation.</abstract><note>Full Papers</note><relatedItem type="host"><titleInfo><title>Journal of Neural Transmission - Parkinson's Disease and Dementia Section</title></titleInfo><titleInfo type="abbreviated"><title>J Neural Transm Gen Sect</title></titleInfo><genre type="Journal" displayLabel="Archive Journal"></genre><originInfo><dateIssued encoding="w3cdtf">1993-02-01</dateIssued><copyrightDate encoding="w3cdtf">1993</copyrightDate></originInfo><subject><genre>Medicine & Public Health</genre><topic>Pharmacology/Toxicology</topic><topic>Psychiatry</topic><topic>Neurology</topic></subject><identifier type="ISSN">0936-3076</identifier><identifier type="eISSN">1435-1463</identifier><identifier type="JournalID">722</identifier><identifier type="IssueArticleCount">9</identifier><identifier type="VolumeIssueCount">3</identifier><part><date>1993</date><detail type="volume"><number>5</number><caption>vol.</caption></detail><detail type="issue"><number>1</number><caption>no.</caption></detail><extent unit="pages"><start>45</start><end>61</end></extent></part><recordInfo><recordOrigin>Springer-Verlag, 1993</recordOrigin></recordInfo></relatedItem><identifier type="istex">338D77248FE54558E599974EF584E5A171C180CD</identifier><identifier type="DOI">10.1007/BF02260914</identifier><identifier type="ArticleID">Art6</identifier><identifier type="ArticleID">BF02260914</identifier><accessCondition type="use and reproduction" contentType="copyright">Springer-Verlag</accessCondition><recordInfo><recordContentSource>SPRINGER</recordContentSource><recordOrigin>Springer-Verlag, 1993</recordOrigin></recordInfo></mods></metadata><enrichments><istex:refBibTEI uri="https://api.istex.fr/document/338D77248FE54558E599974EF584E5A171C180CD/enrichments/refBib"><teiHeader></teiHeader><text><front></front><body></body><back><listBibl><biblStruct xml:id="b0"><analytic><title level="a" type="main">A clinical disability rating for Parkinson patients</title><author><persName><forename type="first">A</forename><surname>Alba</surname></persName></author><author><persName><forename type="first">Fs</forename><surname>Trainor</surname></persName></author><author><persName><forename type="first">W</forename><surname>Ritter</surname></persName></author><author><persName><forename type="first">Mm</forename><surname>Dacso</surname></persName></author></analytic><monogr><title level="j">J Chron Dis</title><imprint><biblScope unit="volume">21</biblScope><biblScope unit="page" from="507" to="522"></biblScope><date type="published" when="1968"></date></imprint></monogr></biblStruct><biblStruct xml:id="b1"><monogr><title level="m" type="main">Salbengesicht Zentrale Dyregulation der Talgsekretion beim Parkinson-Syndrom</title><author><persName><forename type="first">H</forename><surname>Baas</surname></persName></author><author><persName><forename type="first">Pa</forename><surname>Fischer</surname></persName></author><editor>Fischer PA (Hrsg) Vegetativst6rungen beim Parkinson-Syndrom . Editiones Roche</editor><imprint><date type="published" when="1984"></date><biblScope unit="page" from="221" to="234"></biblScope><pubPlace>Basel</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b2"><monogr><title level="m" type="main">Fluktuationen der Beweglichkeit beim Parkinson-Syndrom</title><author><persName><forename type="first">H</forename><surname>Baas</surname></persName></author><author><persName><forename type="first">Pa</forename><surname>Fischer</surname></persName></author><imprint><date type="published" when="1986"></date><biblScope unit="page" from="213" to="233"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b3"><analytic><title level="a" type="main">Die moderne medikamentSse Behandlung des Parkinsonismus</title><author><persName><forename type="first">W</forename><surname>Birkmayer</surname></persName></author><author><persName><forename type="first">E</forename><surname>Neumayer</surname></persName></author></analytic><monogr><title level="j">Z Neurol</title><imprint><biblScope unit="volume">202</biblScope><biblScope unit="page" from="257" to="280"></biblScope><date type="published" when="1972"></date></imprint></monogr></biblStruct><biblStruct xml:id="b4"><analytic><title level="a" type="main">Orthostatische Regulationsst6rung beim Parkinson- Syndrom</title><author><persName><forename type="first">T</forename><surname>Briebach</surname></persName></author><author><persName><forename type="first">H</forename><surname>Baa</surname></persName></author><author><persName><forename type="first">Pa</forename><surname>Fischer</surname></persName></author></analytic><monogr><title level="j">Nervenarzt</title><imprint><biblScope unit="volume">61</biblScope><biblScope unit="page">491494</biblScope><date type="published" when="1990"></date></imprint></monogr></biblStruct><biblStruct xml:id="b5"><analytic><title level="a" type="main">Accuracy of self reported disability in patients with parkinsonism</title><author><persName><forename type="first">Rg</forename><surname>Brown</surname></persName></author><author><persName><forename type="first">B</forename><surname>Mccarthy</surname></persName></author><author><persName><forename type="first">M</forename><surname>Jahanshahi</surname></persName></author><author><persName><forename type="first">Cd</forename><surname>Marsden</surname></persName></author></analytic><monogr><title level="j">Arch Neurol</title><imprint><biblScope unit="volume">46</biblScope><biblScope unit="page" from="955" to="959"></biblScope><date type="published" when="1989"></date></imprint></monogr></biblStruct><biblStruct xml:id="b6"><analytic><title level="a" type="main">A method for evaluating disability in patients with Parkinson's disease</title><author><persName><forename type="first">Gj</forename><surname>Canter</surname></persName></author><author><persName><forename type="first">R</forename><surname>De La Torre</surname></persName></author><author><persName><forename type="first">M</forename><surname>Mier</surname></persName></author></analytic><monogr><title level="j">Nerv Ment Dis</title><imprint><biblScope unit="volume">133</biblScope><biblScope unit="page" from="143" to="147"></biblScope><date type="published" when="1961"></date></imprint></monogr></biblStruct><biblStruct xml:id="b7"><analytic><title level="a" type="main">A computerized tracking technique for the assessment of parkinsonian motor disabilities</title><author><persName><forename type="first">K</forename><surname>Cassell</surname></persName></author><author><persName><forename type="first">K</forename><surname>Shaw</surname></persName></author><author><persName><forename type="first">G</forename><surname>Stern</surname></persName></author></analytic><monogr><title level="j">Brain</title><imprint><biblScope unit="volume">96</biblScope><biblScope unit="page" from="815" to="826"></biblScope><date type="published" when="1973"></date></imprint></monogr></biblStruct><biblStruct xml:id="b8"><analytic><title level="a" type="main">Assessment of rest tremor in Parkinson's disease</title><author><persName><forename type="first">L</forename><surname>Cleeves</surname></persName></author><author><persName><forename type="first">Lj</forename><surname>Findley</surname></persName></author><author><persName><forename type="first">M</forename><surname>Gresty</surname></persName></author></analytic><monogr><title level="j">Adv Neurol</title><imprint><biblScope unit="volume">45</biblScope><biblScope unit="page" from="349" to="352"></biblScope><date type="published" when="1986"></date></imprint></monogr></biblStruct><biblStruct xml:id="b9"><analytic><title level="a" type="main">Evaluating the evaluations: or how to weight the scale of parkinsonian disability</title><author><persName><forename type="first">Sg</forename><surname>Diamond</surname></persName></author><author><persName><forename type="first">Ch</forename><surname>Markham</surname></persName></author></analytic><monogr><title level="j">Neurology</title><imprint><biblScope unit="volume">33</biblScope><biblScope unit="page" from="1098" to="1099"></biblScope><date type="published" when="1983"></date></imprint></monogr></biblStruct><biblStruct xml:id="b10"><monogr><title level="m" type="main">The evaluation of extrapyramidal disease Monoamines, noyeaux gris centraux et syndrome de Parkinson</title><author><persName><forename type="first">Rc</forename><surname>Duvoisin</surname></persName></author><editor>Ajuriaguerra J</editor><imprint><date type="published" when="1970"></date><publisher>Masson</publisher><biblScope unit="page" from="313" to="325"></biblScope><pubPlace>Paris</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b11"><monogr><title level="m" type="main">Unified Parkinson's disease rating scale Recent developments in Parkinson's disease. Macmillian Health Care Information</title><author><persName><forename type="first">S</forename><surname>Fahn</surname></persName></author><author><persName><forename type="first">Rl</forename><surname>Elton</surname></persName></author><author><persName><surname>Updrs Development</surname></persName></author><author><persName><surname>Committee</surname></persName></author><editor>Fahn S, Marsden CD, Calne DB, Goldstein M</editor><imprint><date type="published" when="1987"></date><biblScope unit="page" from="153" to="164"></biblScope><pubPlace>New York</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b12"><analytic><title level="a" type="main">Longterm course in Parkinson's syndrome and cerebral polypathy (Parkinson plus)</title><author><persName><forename type="first">Pa</forename><surname>Fischer</surname></persName></author></analytic><monogr><title level="j">Adv Neurol</title><imprint><biblScope unit="volume">45</biblScope><biblScope unit="page" from="235" to="238"></biblScope><date type="published" when="1986"></date></imprint></monogr></biblStruct><biblStruct xml:id="b13"><analytic><title level="a" type="main">Ordinal scale and statistics in medical research</title><author><persName><forename type="first">M</forename><surname>Forrest</surname></persName></author><author><persName><forename type="first">B</forename><surname>Andersen</surname></persName></author></analytic><monogr><title level="j">Br Med J</title><imprint><biblScope unit="volume">292</biblScope><biblScope unit="page" from="537" to="538"></biblScope><date type="published" when="1986"></date></imprint></monogr></biblStruct><biblStruct xml:id="b14"><analytic><title level="a" type="main">Pharmcotherapy for organic brain syndrome in late life</title><author><persName><forename type="first">Cm</forename><surname>Gaitz</surname></persName></author><author><persName><forename type="first">Rv</forename><surname>Varner</surname></persName></author><author><persName><forename type="first">Je</forename><surname>Overall</surname></persName></author></analytic><monogr><title level="j">Arch Gen Psychiatry</title><imprint><biblScope unit="volume">34</biblScope><biblScope unit="page" from="839" to="845"></biblScope><date type="published" when="1977"></date></imprint></monogr></biblStruct><biblStruct xml:id="b15"><analytic><title level="a" type="main">Prfisentation des Dokumentationsbogens f/Jr Parkinsonkranke der Osterreichischen Parkinsongesellschaft Effects of L-Dopa in Parkinson's disease</title><author><persName><forename type="first">F</forename><surname>Gerstenbrand</surname></persName></author><author><persName><forename type="first">D</forename><surname>Klingler</surname></persName></author><author><persName><forename type="first">W</forename><surname>Poewe</surname></persName></author><author><persName><forename type="first">G</forename><surname>Schnaberth</surname></persName></author></analytic><monogr><title level="j">Lancet</title><editor>Schnaberth G, Auff E (Hrsg) Das Parkinson-Syndrom. Editiones Roche, Wien Godwin-Austen RB, Tomlinson EB, Frears CC, Kok HWL</editor><imprint><biblScope unit="volume">ii</biblScope><biblScope unit="page" from="165" to="168"></biblScope><date type="published" when="1969"></date></imprint></monogr></biblStruct><biblStruct xml:id="b16"><analytic><title level="a" type="main">Depression in Parkinson's disease: a quantitative and qualitative analysis</title><author><persName><forename type="first">Am</forename><surname>Gotham</surname></persName></author><author><persName><forename type="first">Rg</forename><surname>Brown</surname></persName></author><author><persName><forename type="first">Cd</forename><surname>Marsden</surname></persName></author></analytic><monogr><title level="j">J Neurol Neurosurg Psychiatry</title><imprint><biblScope unit="volume">49</biblScope><biblScope unit="page" from="381" to="389"></biblScope><date type="published" when="1986"></date></imprint></monogr></biblStruct><biblStruct xml:id="b17"><analytic><title level="a" type="main">Factur structure of the Sandoz Clinical Assessment Geriatric Scale (SCAG)</title><author><persName><forename type="first">Hb</forename><surname>Hamot</surname></persName></author><author><persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Patin</surname></persName></author><author><persName><forename type="first">Mj</forename><surname>Singer</surname></persName></author></analytic><monogr><title level="j">Psychopharmacol Bull</title><imprint><biblScope unit="volume">20</biblScope><biblScope unit="page" from="142" to="150"></biblScope><date type="published" when="1984"></date></imprint></monogr></biblStruct><biblStruct xml:id="b18"><analytic><title level="a" type="main">An evaluation of the Columbia Scale</title><author><persName><forename type="first">M</forename><surname>Hely</surname></persName></author><author><persName><forename type="first">Jgl</forename><surname>Morris</surname></persName></author><author><persName><forename type="first">A</forename><surname>Wilson</surname></persName></author><author><persName><forename type="first">P</forename><surname>Fahey</surname></persName></author><author><persName><forename type="first">O</forename><surname>Sullivan</surname></persName></author><author><persName><forename type="first">Dj</forename><surname>Williamson</surname></persName></author><author><persName><forename type="first">Pm</forename></persName></author></analytic><monogr><title level="m">European Conference on Parkinson's Disease and Extrapyramidal Disorders</title><editor>Agnoli A</editor><meeting><address><addrLine>Rome London Paris New York</addrLine></address></meeting><imprint><publisher>John Libbey</publisher><date type="published" when="1990"></date><biblScope unit="page">136</biblScope></imprint></monogr><note>Abstract</note></biblStruct><biblStruct xml:id="b19"><analytic><title level="a" type="main">Parkinsonism: onset progression and mortality</title><author><persName><forename type="first">Mm</forename><surname>Hoehn</surname></persName></author><author><persName><forename type="first">Md</forename><surname>Yahr</surname></persName></author></analytic><monogr><title level="j">Neurology</title><imprint><biblScope unit="volume">17</biblScope><biblScope unit="page" from="427" to="442"></biblScope><date type="published" when="1967"></date></imprint></monogr></biblStruct><biblStruct xml:id="b20"><analytic><title level="a" type="main">Quantitative assessment of parkinsonism and essential tremor: clinical application of triaxial accelerometry</title><author><persName><forename type="first">W</forename><surname>Horn</surname></persName></author></analytic><monogr><title level="m">LPS) Handanweisung, 2. Aufl. Hogrefe</title><imprint><date type="published" when="1980"></date><biblScope unit="page">393</biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b21"><analytic><title level="a" type="main">Studies with bromocriptine. Part 1. On-off phenomena</title><author><persName><forename type="first">R</forename><surname>Kartzinel</surname></persName></author><author><persName><forename type="first">Db</forename><surname>Calne</surname></persName></author></analytic><monogr><title level="j">Neurology</title><imprint><biblScope unit="volume">26</biblScope><biblScope unit="page" from="508" to="510"></biblScope><date type="published" when="1976"></date></imprint></monogr></biblStruct><biblStruct xml:id="b22"><analytic><title level="a" type="main">The reliability of clinical assessment of Parkinson's disease</title><author><persName><forename type="first">C</forename><surname>Kennard</surname></persName></author><author><persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Munro</surname></persName></author><author><persName><forename type="first">Dm</forename><surname>Park</surname></persName></author></analytic><monogr><title level="j">J Neurol Neurosurg Psychiatry</title><imprint><biblScope unit="volume">47</biblScope><biblScope unit="page" from="322" to="323"></biblScope><date type="published" when="1984"></date></imprint></monogr></biblStruct><biblStruct xml:id="b23"><analytic><title level="a" type="main">Correlations in 80 patients with Parkinson's disease</title><author><persName><forename type="first">Jj</forename><surname>Korten</surname></persName></author></analytic><monogr><title level="m">Parkinson's disease. Concepts and prospects</title><editor>Lakke JPWF, Korf J, Wesseling H</editor><meeting><address><addrLine>Amsterdam</addrLine></address></meeting><imprint><date type="published" when="1977"></date><biblScope unit="page" from="101" to="110"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b24"><analytic><title level="a" type="main">Classification of extrapyramidal disorders</title><author><persName><forename type="first">Jpwf</forename><surname>Lakke</surname></persName></author></analytic><monogr><title level="j">J Neurol Sci</title><imprint><biblScope unit="volume">51</biblScope><biblScope unit="page" from="311" to="327"></biblScope><date type="published" when="1981"></date></imprint></monogr></biblStruct><biblStruct xml:id="b25"><monogr><title level="m" type="main">Assessment of Parkinson's disease Quantification of neurological deficits</title><author><persName><forename type="first">Aet</forename><surname>Lang</surname></persName></author><author><persName><forename type="first">S</forename><surname>Fahn</surname></persName></author><editor>Munsat T</editor><imprint><date type="published" when="1989"></date><publisher>Butterworth</publisher><biblScope unit="page" from="285" to="309"></biblScope><pubPlace>Boston</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b26"><analytic><title level="a" type="main">Theoretical and practical issues in assessment of deficits and therapy in parkinsonism</title><author><persName><forename type="first">Ta</forename><surname>Larsen</surname></persName></author><author><persName><forename type="first">Pa</forename><surname>Lewitt</surname></persName></author><author><persName><forename type="first">Db</forename><surname>Calne</surname></persName></author></analytic><monogr><title level="m">Lisuride and other dopamine agonists</title><editor>Calne DB, Horowski R, McDonald RJ, Wuttke W</editor><meeting><address><addrLine>New York</addrLine></address></meeting><imprint><publisher>Raven Press</publisher><date type="published" when="1983"></date><biblScope unit="page" from="363" to="373"></biblScope></imprint></monogr></biblStruct><biblStruct xml:id="b27"><analytic><title level="a" type="main">Assessment of Parkinson's disease</title><author><persName><forename type="first">Ta</forename><surname>Larsen</surname></persName></author><author><persName><forename type="first">S</forename><surname>Calne</surname></persName></author><author><persName><forename type="first">Db</forename><surname>Calne</surname></persName></author></analytic><monogr><title level="j">Clin Neuropharmacol</title><imprint><biblScope unit="volume">7</biblScope><biblScope unit="page" from="165" to="169"></biblScope><date type="published" when="1984"></date></imprint></monogr></biblStruct><biblStruct xml:id="b28"><monogr><title level="m" type="main">Evaluation of Parkinson's disease Ergot compounds and brain function. Neuroendocrine and neuropsychiatric aspects</title><author><persName><forename type="first">A</forename><surname>Liebermann</surname></persName></author><author><persName><forename type="first">M</forename><surname>Dziatolowski</surname></persName></author><author><persName><forename type="first">G</forename><surname>Gopinathan</surname></persName></author><author><persName><forename type="first">M</forename><surname>Kopersmith</surname></persName></author><author><persName><forename type="first">A</forename><surname>Neophytides</surname></persName></author><author><persName><forename type="first">J</forename><surname>Korein</surname></persName></author><editor>Goldstein M</editor><imprint><date type="published" when="1980"></date><publisher>Raven Press</publisher><biblScope unit="page" from="277" to="286"></biblScope><pubPlace>New York</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b29"><analytic><title level="a" type="main">Evidence to support early levodopa therapy in Parkinson's disease</title><author><persName><forename type="first">Ch</forename><surname>Markham</surname></persName></author><author><persName><forename type="first">Sg</forename><surname>Diamond</surname></persName></author></analytic><monogr><title level="j">Neurology</title><imprint><biblScope unit="volume">31</biblScope><biblScope unit="page" from="125" to="131"></biblScope><date type="published" when="1981"></date></imprint></monogr></biblStruct><biblStruct xml:id="b30"><analytic><title level="a" type="main">Assessment of extrapyramidal disorders</title><author><persName><forename type="first">Cd</forename><surname>Marsden</surname></persName></author><author><persName><forename type="first">M</forename><surname>Schachter</surname></persName></author></analytic><monogr><title level="j">Br J Clin Pharmacol</title><imprint><biblScope unit="volume">11</biblScope><biblScope unit="page" from="129" to="151"></biblScope><date type="published" when="1981"></date></imprint></monogr></biblStruct><biblStruct xml:id="b31"><monogr><title level="m" type="main">Rating scales in Parkinson's disease</title><author><persName><forename type="first">P</forename><surname>Martinez-Martin</surname></persName></author><author><persName><forename type="first">F</forename><surname>Bermejo-Parejy</surname></persName></author><editor>Jankovic J, Tolosa E</editor><imprint><date type="published" when="1988"></date><publisher>Urban & Schwarzenberg</publisher><pubPlace>Baltimore Munich</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b32"><analytic><title level="a" type="main">Treatment of Parkinson's syndrome with dihydroxyphenylalanine (levodopa)</title><author><persName><forename type="first">Mc</forename><surname>Dowell</surname></persName></author><author><persName><forename type="first">F</forename><surname>Lee</surname></persName></author><author><persName><forename type="first">Je</forename><surname>Swift</surname></persName></author><author><persName><forename type="first">T</forename><surname>Sweet</surname></persName></author><author><persName><forename type="first">Rd</forename><surname>Ogsbury</surname></persName></author><author><persName><forename type="first">Js</forename><surname>Tessler</surname></persName></author><author><persName><forename type="first">Jt</forename></persName></author></analytic><monogr><title level="j">Ann Intern Med</title><imprint><biblScope unit="volume">72</biblScope><biblScope unit="page" from="29" to="35"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b33"><analytic><title level="a" type="main">PD and Columbia Scale</title><author><persName><forename type="first">Gk</forename><surname>Montgomery</surname></persName></author></analytic><monogr><title level="j">Neurology</title><imprint><biblScope unit="volume">34</biblScope><biblScope unit="page" from="557" to="558"></biblScope><date type="published" when="1984"></date></imprint></monogr></biblStruct><biblStruct xml:id="b34"><analytic><title level="a" type="main">Qualitative assessment of Parkinson's disease: study of reliability and data reduction with an abbreviated Columbia scale</title><author><persName><forename type="first">Gk</forename><surname>Montgomery</surname></persName></author><author><persName><forename type="first">Nc</forename><surname>Reynolds</surname></persName></author><author><persName><forename type="first">Rm</forename><surname>Warren</surname></persName></author></analytic><monogr><title level="j">Clin Neuropharmacol</title><imprint><biblScope unit="volume">8</biblScope><biblScope unit="page" from="83" to="92"></biblScope><date type="published" when="1985"></date></imprint></monogr></biblStruct><biblStruct xml:id="b35"><analytic><title level="a" type="main">a) Controlled trial of amantadine hydrichloride in Parkinson's disease</title><author><persName><forename type="first">Jd</forename><surname>Parkes</surname></persName></author><author><persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Zilkha</surname></persName></author><author><persName><forename type="first">Dm</forename><surname>Calver</surname></persName></author><author><persName><forename type="first">Rp</forename><surname>Knill-Jones</surname></persName></author></analytic><monogr><title level="j">Lancet</title><imprint><biblScope unit="volume">i</biblScope><biblScope unit="page" from="259" to="262"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b36"><analytic><title level="a" type="main">Amantadine dosage in treatment of Parkinson's disease</title><author><persName><forename type="first">Jd</forename><surname>Parkes</surname></persName></author><author><persName><forename type="first">Kj</forename><surname>Zilkha</surname></persName></author><author><persName><forename type="first">Cd</forename><surname>Marsden</surname></persName></author><author><persName><forename type="first">Rch</forename><surname>Baxter</surname></persName></author><author><persName><forename type="first">Rp</forename><surname>Knill-Jones</surname></persName></author></analytic><monogr><title level="j">Lancet</title><imprint><biblScope unit="volume">i</biblScope><biblScope unit="page" from="1130" to="1133"></biblScope><date type="published" when="1970"></date></imprint></monogr></biblStruct><biblStruct xml:id="b37"><analytic><title level="a" type="main">Behavioural changes in Parkinson patients. A factor analytical study</title><author><persName><forename type="first">L</forename><surname>Petrinovich</surname></persName></author><author><persName><forename type="first">C</forename><surname>Hardyck</surname></persName></author></analytic><monogr><title level="j">J Chron Dis</title><imprint><biblScope unit="volume">17</biblScope><biblScope unit="page" from="225" to="233"></biblScope><date type="published" when="1964"></date></imprint></monogr></biblStruct><biblStruct xml:id="b38"><analytic><title level="a" type="main">The neurological examination: advancements in its quantification</title><author><persName><forename type="first">Ar</forename><surname>Potvin</surname></persName></author><author><persName><forename type="first">Ww</forename><surname>Tourtelotte</surname></persName></author></analytic><monogr><title level="j">Arch Phys Med Rehabil</title><imprint><biblScope unit="volume">56</biblScope><biblScope unit="page" from="425" to="437"></biblScope><date type="published" when="1975"></date></imprint></monogr></biblStruct><biblStruct xml:id="b39"><monogr><title level="m" type="main">Projection technique for evaluating surgery in Parkinson's disease</title><author><persName><forename type="first">Rs</forename><surname>Schwab</surname></persName></author><author><persName><forename type="first">Rc</forename><surname>England</surname></persName></author><editor>Gillingham F J, Donaldson MC</editor><imprint><date type="published" when="1969"></date><pubPlace>Edinburgh</pubPlace></imprint></monogr><note>3rd. Symposium on Parkinson's Disease . E. S. Livingstone</note></biblStruct><biblStruct xml:id="b40"><analytic><title level="a" type="main">A new scale for clinical assessment on geriatric populations: SANDOZ Clinical Assessment Geriatric (SCAG)</title><author><persName><forename type="first">Ri</forename><surname>Shader</surname></persName></author><author><persName><forename type="first">Js</forename><surname>Harmatz</surname></persName></author><author><persName><forename type="first">C</forename><surname>Salzman</surname></persName></author></analytic><monogr><title level="j">J Am Geriatr Soc</title><imprint><biblScope unit="volume">22</biblScope><biblScope unit="page" from="107" to="113"></biblScope><date type="published" when="1974"></date></imprint></monogr></biblStruct><biblStruct xml:id="b41"><analytic><title level="a" type="main">Frontal lobe dysfunction in Parkinson's disease: the cortical focus of neostriatal outflow</title><author><persName><forename type="first">Ae</forename><surname>Taylor</surname></persName></author><author><persName><forename type="first">Ja</forename><surname>Saint-Cyr</surname></persName></author><author><persName><forename type="first">Ae</forename><surname>Lang</surname></persName></author></analytic><monogr><title level="j">Brain</title><imprint><biblScope unit="volume">109</biblScope><biblScope unit="page" from="845" to="883"></biblScope><date type="published" when="1986"></date></imprint></monogr></biblStruct><biblStruct xml:id="b42"><monogr><title level="m" type="main">Quantitative assessment of Parkinsonian deficits Parkinson's disease-current progress, problems and management</title><author><persName><forename type="first">H</forename><surname>Teravainen</surname></persName></author><author><persName><forename type="first">Db</forename><surname>Calne</surname></persName></author><editor>Rinne UK, Klinger M, Stamm G</editor><imprint><date type="published" when="1980"></date><publisher>Elsevier</publisher><biblScope unit="page" from="145" to="164"></biblScope><pubPlace>Amsterdam</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b43"><monogr><title level="m" type="main">Purdue pegboard. Examiner manual. Lafayette Instruments Company, Reorder Nr</title><author><persName><forename type="first">J</forename><surname>Tiffin</surname></persName></author><imprint><date type="published" when="1979"></date><biblScope unit="page" from="7" to="435"></biblScope><pubPlace>Lafayette 2</pubPlace></imprint></monogr></biblStruct><biblStruct xml:id="b44"><analytic><title level="a" type="main">A quantitative evaluation of the effects of L-Dopa on Parkinson's disease</title><author><persName><forename type="first">F</forename><surname>Velasco</surname></persName></author><author><persName><forename type="first">M</forename><surname>Velasco</surname></persName></author></analytic><monogr><title level="j">Neuropharmacology</title><imprint><biblScope unit="volume">12</biblScope><biblScope unit="page" from="89" to="99"></biblScope><date type="published" when="1973"></date></imprint></monogr></biblStruct><biblStruct xml:id="b45"><analytic><title level="a" type="main">Methods for evaluating treatment in Parkinson's disease</title><author><persName><forename type="first">Cd</forename><surname>Ward</surname></persName></author><author><persName><forename type="first">Jn</forename><surname>Sane</surname></persName></author><author><persName><forename type="first">Jm</forename><surname>Dambrosia</surname></persName></author></analytic><monogr><title level="j">Advances in neurology</title><editor>Fahn S, Calne DB, Shoulson I</editor><imprint><publisher>Raven Press</publisher><publisher>Raven Press</publisher><biblScope unit="volume">37</biblScope><biblScope unit="page" from="1" to="7"></biblScope><date type="published" when="1983"></date></imprint></monogr></biblStruct><biblStruct xml:id="b46"><analytic><title level="a" type="main">Critical analysis of the disability in Parkinson's disease Mod Treat 5: 257-282 wiener Determinationsger Treatment of parkinsonism with levodopa</title><author><persName><forename type="first">Dd</forename><surname>Webster</surname></persName></author></analytic><monogr><title level="j">Arch Neurol</title><imprint><biblScope unit="volume">21</biblScope><biblScope unit="page" from="343" to="354"></biblScope><date type="published" when="1968"></date></imprint></monogr></biblStruct><biblStruct xml:id="b47"><analytic><title></title><author><persName><forename type="first">D</forename><surname>Zerssen V</surname></persName></author><author><persName><forename type="first">Dm</forename><surname>Koeller</surname></persName></author><author><persName><forename type="first">Er</forename><surname>Rey</surname></persName></author></analytic><monogr><title level="j">Die Befindlichkeits-Skala. Ein einfaches Instrument zur Objektivierung von Befindlichkeitsstrrungen Arzneimittelforschung/Drug Res</title><imprint><biblScope unit="volume">20</biblScope><biblScope unit="page" from="915" to="918"></biblScope><date type="published" when="19700"></date></imprint></monogr></biblStruct></listBibl></back></text></istex:refBibTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000204 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000204 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:338D77248FE54558E599974EF584E5A171C180CD
|texte= Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |